Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftment-Reference-Cited by-同舟云学术

Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftment

Published:2011-08-24 Issue:3 Volume:52 Page:549-559
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:

Author:

Duggleby Richard C.,Querol Sergio,Davy Robert C.,Fry Laura J.,Gibson Daniel A.,Horton Roger B.V.,Mahmood Salmah N.,Gomez Susana G.,Madrigal J. Alejandro

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2011.03305.x/fullpdf

Reference28 articles.

1. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose;Pulsipher;Blood,2009

2. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival;Wagner;Blood,2002

4. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients;Yoo;Bone Marrow Transplant,2007

5. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation;de Boer;Bone Marrow Transplant,2002

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay;Cytotherapy;2022-09

2. Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project team;Cytotherapy;2022-05

3. Role of flow cytometry in evaluation of the cellular therapy products used in haematopoietic stem cell transplantation;International Journal of Laboratory Hematology;2022-04-13

4. Cryopreserved hematopoietic stem/progenitor cells stability program‐development, current status and recommendations: A brief report from the AABB‐ISCT joint working group cellular therapy product stability project team;Transfusion;2022-03

5. Therapeutic Potential of Annexins in Sepsis and COVID-19;Frontiers in Pharmacology;2021-09-09